Women's Reproductive Health

Journal Information
ISSN / EISSN: 23293691 / 23293713
Published by: Informa UK Limited
Total articles ≅ 274

Latest articles in this journal

, Alex Ker, , Elizabeth Kerekere, ,
Published: 26 December 2022
Women's Reproductive Health pp 1-17; https://doi.org/10.1080/23293691.2022.2155496

Transgender and nonbinary (trans) people can face unique barriers to accessing gender-inclusive perinatal care. The present study explored trans people’s experiences of perinatal care in Aotearoa New Zealand. A thematic analysis of 17 interviews with trans people and their whānau identified seven themes regarding the operation and impact of cisnormativity on participants’ family-building journeys. Findings indicate that cisnormativity manifests as an erasure of gender diversity and creates barriers to affirming and safe care. Importantly, participants’ constant negotiation of cisnormativity in perinatal care had enduring impacts on their well-being. Addressing cisnormativity is fundamental to securing trans reproductive justice.
Published: 19 December 2022
Women's Reproductive Health pp 1-19; https://doi.org/10.1080/23293691.2022.2150106

Reproductive health care is characterized by pervasive cisnormativity and trans erasure. Trans people therefore must employ improvisational tactics to access and navigate these spaces, including deciding whether, when, and how to disclose their gender identities. Drawing on the experiences of four nonbinary people from British Columbia, Canada, this qualitative discourse analysis explores how identity disclosures created opportunities for ad hoc education of ill-prepared providers and how identity concealment may be used to mitigate the risks of being identifiable/identified as trans. This analysis demonstrates how identity disclosures alone are insufficient for ensuring that nonbinary people have affirming reproductive health care experiences.
Published: 15 December 2022
Women's Reproductive Health pp 1-16; https://doi.org/10.1080/23293691.2022.2150105

This study using data from the 2015 to 2018 National Survey on Drug Use and Health examined prescription opioid use and misuse among pregnant women with sensory, cognitive, or daily activities–related disabilities. Pregnant women with any type of disability had higher adjusted odds of using (AOR, 1.71; 95% confidence interval [CI], 1.27–2.29) and misusing (AOR, 2.00; 95% CI, 1.22–3.28) opioids within the past year. Pain relief (59.5%) was the greatest motive for last opioid misuse. Approximately, 45% of women acquired opioids from friends/relatives and 25% obtained opioids from other non-medical sources. Pregnant women with disabilities are at increased risk for prescription opioid use and misuse.
Published: 29 November 2022
Women's Reproductive Health pp 1-24; https://doi.org/10.1080/23293691.2022.2132841

Preconception care for people with chronic health conditions is recommended in view of the implications for them and their offspring during pregnancy and beyond. This realist review of published and grey literature explored factors that explain why people seek or receive appropriate preconception counseling and why they engage in recommended health behavior change prior to pregnancy. Fifty-two studies contributed to phase one synthesis, and 38 studies provided explanations in phase two. Ten program theories were developed, explored, and refined through iterative discussion and coding. Causal explanations of the ways in which components of preconception care contribute to effective access to care and prepregnancy behavior change were identified. Beneficial components included continuity of carer (promoting trust), a partnership approach (empowering people who feel valued), promoting an integrated approach across primary and secondary care, offering psychological counseling (recognizing the link between physical and psychosocial aspects of living with health conditions), considering sexual and reproductive health as part of routine care, and normalizing conversations about preconception care (to reduce the barrier created by social and cultural norms). These key aspects have been highlighted for consideration when planning, implementing, and improving preconception care services for people with health conditions.
Published: 28 November 2022
Women's Reproductive Health pp 1-18; https://doi.org/10.1080/23293691.2022.2146913

This article recounts two moments in which revolutions in assisted reproductive technologies (ARTs) opened clinical questions and public debate about whether transgender women should receive doctors’ help to become pregnant. The first took place in Australia in the 1980s when advancements in in vitro fertilization and the accident of a full-term abdominal pregnancy opened the potential that people without uteruses could become pregnant. Critics of reproductive technology used the figure of “the pregnant transsexual” to represent the dangers of science and scientists run amok. Now nearly 40 years later, some advocates argue that trans women could receive uterus transplants to become pregnant. Critics have seized on this suggestion to ask whether all women deserve complex reproductive assistance. Based on archival research and interviews with specialist surgeons, I compare these two moments to examine how the figure of the pregnant trans woman has shaped debates about ARTs and how the possible use of ARTs has shaped discussions of the maternal status of trans women. Consistent across these moments is a recognition of ARTs as themselves gender-confirming technologies. The power of their use to confer a fundamental femininity has pervaded anxieties about trans women as beneficiaries of ARTs.
Cassie Hobbs, Gabrielle Jude, Han-Yang Chen, Megha Gupta, Michal Fishel Bartal, Suneet P. Chauhan,
Published: 28 November 2022
Women's Reproductive Health pp 1-9; https://doi.org/10.1080/23293691.2022.2146471

The objective of this work is to compare the rate of spontaneous preterm birth and associated neonatal morbidity among low-risk pregnancies conceived spontaneously versus pregnancies conceived using infertility medications/intrauterine insemination (IFM/IUI). This population-based retrospective cohort study utilized the US Vital Statistics data set from 2015 to 2019. Low-risk pregnancies, resulting in a live birth, of individuals who conceived either spontaneously or with the assistance of IFM/IUI were examined. The primary measured outcome was the rate of spontaneous preterm delivery, defined as delivery before 37 weeks’ gestation without induction of labor. Of the 19,382,574 deliveries during the study period, 7,876,515 (40.6%) met the inclusion criteria. While 7,843,328 (99.6%) conceived spontaneously, 33,187 (0.4%) conceived using IFM/IUI. The rate of spontaneous preterm delivery was significantly higher for patients who conceived using IFM/IUI (71.0 per 1,000 live births) compared to patients who conceived spontaneously (60.3 per 1,000 live births; adjusted relative risk, 1.40; 95% confidence interval, 1.35–1.46). While the rate of spontaneous preterm births and associated composite of neonatal adverse outcomes are significantly higher in pregnancies conceived using IFM/IUI than spontaneous conception, the mortality is similar.
, Tracy Nichols
Published: 22 November 2022
Women's Reproductive Health pp 1-18; https://doi.org/10.1080/23293691.2022.2142492

Refugee maternal health is an under-studied area in health science research since refugee women have complex health histories that consistently change throughout their resettlement journey. This study examined setting-based maternal health understanding among Bhutanese refugee women resettled in Greensboro, NC. We utilized qualitative case-study methods to examine n = 12 interviews within three different cases based on birth settings. Themes around women’s experiences of familial support, impact of setting-based maternal health access, and quality of care experienced were significant findings. Study aims were to help providers improve patient-provider interaction in relaying adequate care information and assess women’s pre-settlement health history for appropriate care.
Published: 27 October 2022
Women's Reproductive Health pp 1-3; https://doi.org/10.1080/23293691.2022.2136585

Wimbledon, the annual grand slam held in England from late June through the first week of July, grabbed headlines with its policy requiring players to wear white. Catherine Whitaker, a commentator ...
Back to Top Top